TELADOC HEALTH sees an upgrade to Slightly Negative thanks to a better star rating, but the title remains unattractive
The independent financial analyst theScreener just awarded an improved star rating to TELADOC HEALTH (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 1 out of 4 possible stars. Given its market behaviour as risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Slightly Negative; the title, however, remains unattractive. As of the analysis date March 18, 2022, the closing price was USD 68.96 and its target price was estimated at USD 50.35.Teladoc Health is a provider of virtual healthcare services. The company provides virtual access to care and capabilities, with a portfolio of services and solutions covering medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to medical conditions like cancer and congestive heart failure. In its behavioral health business, branded BetterHelp, the company serves individuals in the direct-to-consumer market and through business partnerships with other brands. The company's consumer brands, which include Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou, deliver access to advice and resolution to an array of healthcare needs.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.